×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 3: Application of AI & ML in Discovering Drug Development
Session Chair(s)
Niels Buch Leander, PhD
Associate Vice President, Global Head of Regulatory Affairs
NNIT, Denmark
Session 3: Application of AI & ML in Discovering Drug Development
Speaker(s)
Embracing Real World Evidence (RWE) & Robotic Process Automation to transform Regulatory Affairs Submission Process
Susant Mallick, MBA
Cloudhub BV, Netherlands
Founder and CEO, Life Sciences Practice Leader
Have an account?